← Open Payments lookup

JANNETTE VILLAFRANCA: Open Payments

NPI 1528614815 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,493 in 64 payments from 17 companies in 2025. Trend: 2023 $1,550 · 2024 $2,472 · 2025 $1,493

Food & beverage: $1,493
CompanyPaymentsAmount
UCB, Inc.13$384
Eisai Inc.9$211
ABBVIE INC.7$150
Lilly USA, LLC8$133
Takeda Pharmaceuticals U.S.A., Inc.4$105
Novartis Pharmaceuticals Corporation3$66
SPR Therapeutics, Inc2$64
Biogen, Inc.3$61
TerSera Therapeutics LLC2$52
Boston Scientific Corporation2$47

Products named: Leqembi, Fintepla, AMYVID, BOTOX, HYQVIA, Briviact, Nayzilam, KESIMPTA.

Industry payments across TX — which companies pay providers there.